A new survey has revealed that over 79% of Canadians support psychedelic-assisted therapy for existential distress at the end of...
Ketamine is an FDA-approved medical anesthetic and recently a prescription nasal spray version of ketamine called esketamine (Spravato) was approved for treatment-resistant depression.
I typically write about psilocybin, the hallucinogenic compound in mushrooms.
A report has revealed that the consumption of ayahuasca is increasing in several countries.
The University of Exeter, UK, has launched the world’s first post-graduate course on psychedelics.
Following all the hype generated about the therapeutic powers of psychedelics by Michael Pollan’s 2018 book How to Change Your Mind and follow up 2022 Netflix...
The placebo effect is the mysterious power our minds have to make us feel better, even when we are taking just a sugar pill instead of...
MIND Foundation’s INSIGHT Conference took place from August 31 to September 3 in Berlin, exploring the latest frontiers in psychedelic medicines – from clinical developments to...
Psychedelics have specific drug actions, such as inducing structural and functional neural plasticity, that could potentially treat mental health conditions and impact diseases affecting the brain,...
Ketamine has been an FDA-approved medical anaesthetic since 1970, and in the early 2000s a ground-breaking discovery was made about the antidepressant effects of ketamine.
